Member Info for mystic

over next few weeks, year end results due end of may early june

Next stop 7p

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=PCTN&ArticleCode=7xjvb1pc&ArticleHeadline=NAV_and_Dividend

Buying opportunity IMO DYOR

so many directors buying !

Damn good results yet a decline in SP ????

Well done UNG ! http://www.investegate.co.uk/universe-grp---ung-/rns/preliminary-results/201504130700149367J/

Horace, if DODS performs like I exoect it to.. I will be joining LA on his island for sure 8-)

I suspect , judging by the individual transactions today IMO DYOR

500k buy !

At full ask !

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=AMA&ArticleCode=txzjwx82&ArticleHeadline=2014_Audited_Full_Year_Results

Nice addition http://www.investegate.co.uk/universe-grp-/ung/acquisition/201504070700173954J/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=Universe%20Grp.%20Alert

http://www.investegate.co.uk/rm2-international-sa/rm2/director-pdmr-shareholding/201504020700152554J/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=RM2%20International%20SA%20Alert

Belize City, Belize, April 1, 2015 -- BCB Holdings Limited (London - AIM: BCB; Bermuda - BBHL) (the "Company" or "BCBHL") The Company reported a net loss from operations of $4.0m for the three months ended December 31, 2014 (2013 - net loss of $2.7m), and a net loss per ordinary share from continuing operations for the three months of $0.04 (2013 - net loss per share of $0.03). The Company reported a net loss from operations of $2.0m for the nine months ended December 31, 2014 (2013 - net loss of $4.8m), and a net loss per ordinary share from continuing operations for the nine months of $0.02 (2013 - net loss per share of $0.05).

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=22623393&ArticleHeadline=Lord_Ashcroft_steps_down_from_the_House_of_Lords

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=22623393&ArticleHeadline=Lord_Ashcroft_steps_down_from_the_House_of_Lords

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=22623393&ArticleHeadline=Lord_Ashcroft_steps_down_from_the_House_of_Lords

To good to resist in my humble opinion

"Most exciting has been the striking productivity of our drug discovery engine. The investment and enhancements we have made over the past two years are paying dividends, not only with the number of molecules we can now screen, but in the groundbreaking yields we are observing. We have a wealth of active molecules to choose from to take forward into development. "The combination of these successes in 2014/15 with a strong balance sheet heralds another twelve months of major advancement and progress."